32625064|t|Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease.
32625064|a|Huntington's disease (HD) is an inherited neurodegenerative disorder in which the striatum is the most affected brain region. Although a chronic inflammatory microglial reaction that amplifies disease progression has been described in HD patients, some murine models develop symptoms without inflammatory microglial activation. Thus, dysfunction of non-inflammatory microglial activity could also contribute to the early HD pathological process. Here, we show the involvement of microglia and particularly fractalkine signaling in the striatal synaptic dysfunction of R6/1 mice. We found reduced fractalkine gene expression and protein concentration in R6/1 striata from 8 to 20 weeks of age. Consistently, we also observed a down-regulation of fractalkine levels in the putamen of HD patients and in HD patient hiPSC-derived neurons. Automated cell morphology analysis showed a non-inflammatory ramified microglia in the striatum of R6/1 mice. However, we found increased PSD-95-positive puncta inside microglia, indicative of synaptic pruning, before HD motor symptoms start to manifest. Indeed, microglia appeared to be essential for striatal synaptic function, as the inhibition of microglial activity with minocycline impaired the induction of corticostriatal long-term depression (LTD) in wild-type mice. Notably, fractalkine administration restored impaired corticostriatal LTD in R6/1 mice. Our results unveil a role for fractalkine-dependent neuron-microglia interactions in the early striatal synaptic dysfunction characteristic of HD.
32625064	8	19	Fractalkine	Gene	20312
32625064	64	72	Deficits	Disease	MESH:D009461
32625064	76	96	Huntington's Disease	Disease	MESH:D006816
32625064	98	118	Huntington's disease	Disease	MESH:D006816
32625064	120	122	HD	Disease	MESH:D006816
32625064	130	166	inherited neurodegenerative disorder	Disease	MESH:D020271
32625064	243	255	inflammatory	Disease	MESH:D007249
32625064	333	335	HD	Disease	MESH:D006816
32625064	336	344	patients	Species	9606
32625064	351	357	murine	Species	10090
32625064	390	402	inflammatory	Disease	MESH:D007249
32625064	451	463	inflammatory	Disease	MESH:D007249
32625064	519	521	HD	Disease	MESH:D006816
32625064	604	615	fractalkine	Gene	20312
32625064	642	662	synaptic dysfunction	Disease	MESH:C536122
32625064	666	670	R6/1	CellLine	CVCL:D507
32625064	671	675	mice	Species	10090
32625064	694	705	fractalkine	Gene	20312
32625064	751	755	R6/1	CellLine	CVCL:D507
32625064	843	854	fractalkine	Gene	6376
32625064	880	882	HD	Disease	MESH:D006816
32625064	883	891	patients	Species	9606
32625064	899	901	HD	Disease	MESH:D006816
32625064	902	909	patient	Species	9606
32625064	981	993	inflammatory	Disease	MESH:D007249
32625064	1032	1036	R6/1	CellLine	CVCL:D507
32625064	1037	1041	mice	Species	10090
32625064	1071	1077	PSD-95	Gene	13385
32625064	1151	1153	HD	Disease	MESH:D006816
32625064	1309	1320	minocycline	Chemical	MESH:D008911
32625064	1368	1383	term depression	Disease	MESH:D000088562
32625064	1403	1407	mice	Species	10090
32625064	1418	1429	fractalkine	Gene	20312
32625064	1486	1490	R6/1	CellLine	CVCL:D507
32625064	1491	1495	mice	Species	10090
32625064	1527	1538	fractalkine	Gene	20312
32625064	1601	1621	synaptic dysfunction	Disease	MESH:C536122
32625064	1640	1642	HD	Disease	MESH:D006816
32625064	Association	MESH:D009461	20312
32625064	Negative_Correlation	MESH:D008911	MESH:D000088562
32625064	Negative_Correlation	MESH:D006816	6376
32625064	Negative_Correlation	MESH:D006816	20312
32625064	Association	MESH:C536122	20312

